INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![Documentation-getty-1349390515]( "Go From Three Meetings To One With AI-Enabled eCOA")
Go From Three Meetings To One With AI-Enabled eCOALearn how to turn three meetings into one with AI that is streamlining clinical workflows by reducing redundant steps, simplifying site operations, and accelerating data collection.
-
![GettyImages-1804103202 Hiring, Recruiting, Selecting the right candidate]( "Why Use Scorecards To Make Vendor Selection Decisions")
Why Use Scorecards To Make Vendor Selection DecisionsScorecards enable structured, unbiased vendor selection by transforming complex clinical trial decisions into transparent, data-driven evaluations — ensuring operational excellence and regulatory compliance.
-
![GettyImages-545581230-lab-research-computer-tablet-teamwork]( "The Rise Of Targeted Modalities In Pharmaceutical Development")
The Rise Of Targeted Modalities In Pharmaceutical DevelopmentTargeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.
-
![GettyImages-1452403953-patient-recruitment-selection]( "Reframing Vendor Selection: Beyond Price And Past Relationships")
Reframing Vendor Selection: Beyond Price And Past RelationshipsAn RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.
-
Navigating The New Landscape Of Oncology Clinical Trials: A Strategic Imperative For Operations Teams6/18/2026
The oncology landscape is growing but faces high screen-fail rates and trial complexity. To succeed, teams must move past traditional playbooks and adopt centralized pre-screening pipelines.
-
Stay Audit-Ready: Practical Compliance Insights For Research Sites3/26/2026
Gain an auditors insight into common compliance gaps and learn practical ways to strengthen audit readiness in sIRB studies.
-
Tips And Tricks For Developing Rare Cancer Clinical Trials2/6/2025
Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.
-
Consolidating Access Into A Single Platform: A Site CEO's Perspective2/28/2025
By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.
-
Expedite Drug Development With An Integrated CDMO-CRO Model2/6/2026
From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1319939893-car-travel-road]( "Greenphire Travel")
With dedicated coordinators and multilingual staff worldwide, Greenphire ensures smooth, compassionate travel experiences — removing barriers to participation and enhancing trial accessibility.
-
![logistics-discovery-transport-travel-GettyImages-1287428874]( "Safe-To-Site Initiative")
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
![GettyImages-576902490 meeting presentation]( "Biotech-Tailored Clinical Development")
Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.
-
![GettyImages-1293373244 clinical team]( "Global Site Partnership Network")
Accelerate your clinical trials with an expansive network of over 2,000 high-quality, trusted clinical trial sites across Australia, New Zealand, United States and Canada.
-
![doctor and patient consultation-GettyImages-2101007339]( "Clinical Safety Services In FSP Models")
Selecting the right functional service provider (FSP) for safety services is fundamental to protecting patients and requires a resilient, strategic partnership that enhances trial integrity and outcomes.
